These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation. Levi O; Dolev I; Belinson H; Michaelson DM J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042 [TBL] [Abstract][Full Text] [Related]
3. Virology. Alzheimer's risk factor also aids HIV. Youngsteadt E Science; 2008 Jun; 320(5883):1577. PubMed ID: 18566258 [No Abstract] [Full Text] [Related]
4. Additional evidence for antagonistic pleiotropic effects of APOE. Zetterberg H; Alexander DM; Spandidos DA; Blennow K Alzheimers Dement; 2009 Jan; 5(1):75. PubMed ID: 19118812 [No Abstract] [Full Text] [Related]
5. Early intervention in Alzheimer disease: The importance of APOE4 plus family history. Corder EH; Caskey J Neurology; 2009 Dec; 73(24):2054-5. PubMed ID: 20007523 [No Abstract] [Full Text] [Related]
6. Apolipoprotein E genotype and cerebral palsy. Blackman JA Dev Med Child Neurol; 2010 Jul; 52(7):600. PubMed ID: 20059521 [No Abstract] [Full Text] [Related]
7. Genetics. Once shunned, test for Alzheimer's risk headed to market. Couzin J Science; 2008 Feb; 319(5866):1022-3. PubMed ID: 18292309 [No Abstract] [Full Text] [Related]
8. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Hulette CM; Welsh-Bohmer K Neurology; 2007 Feb; 68(6):471; author reply 471. PubMed ID: 17283328 [No Abstract] [Full Text] [Related]
9. Disclosure of the genetic risk of Alzheimer's disease. Gordon SC; Landa D N Engl J Med; 2010 Jan; 362(2):181-2; author reply 182. PubMed ID: 20071713 [No Abstract] [Full Text] [Related]
10. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. Lee HG; Zhu X; Castellani RJ; Nunomura A; Perry G; Smith MA J Pharmacol Exp Ther; 2007 Jun; 321(3):823-9. PubMed ID: 17229880 [TBL] [Abstract][Full Text] [Related]
12. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Han SD; Bondi MW Alzheimers Dement; 2008 Jul; 4(4):251-4. PubMed ID: 18631975 [TBL] [Abstract][Full Text] [Related]
13. Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice. Levi O; Michaelson DM J Neurochem; 2007 Jan; 100(1):202-10. PubMed ID: 17074063 [TBL] [Abstract][Full Text] [Related]
14. The effect of APOE genotype on clinical phenotype in Alzheimer disease. Borroni B; Di Luca M; Padovani A Neurology; 2007 Feb; 68(8):624; author reply 624. PubMed ID: 17310043 [No Abstract] [Full Text] [Related]
16. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease. Poli M; Gatta LB; Lovati C; Mariani C; Galimberti D; Scarpini E; Biunno I; Musicco M; Dominici R; Albertini A; Finazzi D Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415 [TBL] [Abstract][Full Text] [Related]
17. NIH-funded research provides new clues on how ApoE4 affects Alzheimer's risk. Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):356-7. PubMed ID: 22991704 [No Abstract] [Full Text] [Related]